 "Samie Modak")
Samie Modak
Samie Modak
Samie Modak is a market hawk with nearly two decades of experience. At Business Standard, he leads a team of reporters that turns complex market data into captivating stories. Off the clock, he's a tech geek, always up to date with the latest in gadgets, mobiles, and motorbikes. A sports enthusiast, he avidly follows cricket and tennis. With his blend of market expertise, tech passion, and sports fandom, he brings a fresh, engaging perspective to financial journalism.
Samie Modak is a market hawk with nearly two decades of experience. At Business Standard, he leads a team of reporters that turns complex market data into captivating stories. Off the clock, he's a tech geek, always up to date with the latest in gadgets, mobiles, and motorbikes. A sports enthusiast, he avidly follows cricket and tennis. With his blend of market expertise, tech passion, and sports fandom, he brings a fresh, engaging perspective to financial journalism.
Page 98 - Samie Modak/workspace/business Standard Web/video
As Budget fails to lift stocks, it's back to global cues
Like any Budget Day, the stock prices gyrated, and the Sensex swung 850 points, touching a low of 22,495 and a high of 23,343
 "As Budget fails to lift stocks, it's back to global cues")
 "Contra buying emerges in Crompton Greaves")
 "February blues for equities")
 "TeamLease's grey market premium up")
 "When China catches cold")
Market stares at volatility as easy-money era set to end
US Fed rate rise raises risk of further drying up of FII flows as cost of capital would increase
 "Market stares at volatility as easy-money era set to end")
Stuck IPOs of Thyrocare, RBL Bank may get a relief
Sebi's decision to not penalise unlisted entities for violation of public issue norms may boost public offering plans of other companies as well
 "Stuck IPOs of Thyrocare, RBL Bank may get a relief")
Our 2016 year-end Sensex target is 30,000: Saumil Shah
Interview with MD & head of equity sales trading, Bank of America Merrill Lynch
 "Our 2016 year-end Sensex target is 30,000: Saumil Shah")
 "Bankers court Lodha for Rs 2,500-crore IPO")
 "Nifty might again test 2015 lows")
Stocks with hiked promoter stakes beat market
But, experts say, buying into companies on insider buying might not work in a bear market
 "Stocks with hiked promoter stakes beat market")
Focus on pharma IPOs next week
Sources say Alkem Laboratories' Rs 1,350-crore IPO and Dr Lal PathLabs' Rs 633-crore IPO will open from December 7 to 9
Failing to keep growth above 7.5% can hit India badly: Geoffrey Dennis
Interview with Head of global emerging markets strategy, UBS Investment Bank
 "Failing to keep growth above 7.5% can hit India badly: Geoffrey Dennis")
Global woes pose challenge to FY16 disinvestment plan
Govt raises Rs 12,700 cr in Apr-Nov; however, weakness in commodity will weigh on future divestment
 "Global woes pose challenge to FY16 disinvestment plan")
NSE, BSE near deals to cut stakes in depository arms
NSE has around 25% in NSDL, while BSE's holding in CDSL is around 54%
 "NSE, BSE near deals to cut stakes in depository arms")
 "Amfi to take up MF officials' salary structure")
Worst of EM outflows could be over: Anant Shirgaonkar
Interview with Head of India equities, UBS
 "Worst of EM outflows could be over: Anant Shirgaonkar")
Sebi frowns at low retail IPO demand
Plans to raise issue with investment bankers
 "Sebi frowns at low retail IPO demand")
 "Prem Watsa's hands-off approach in India")